Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

NCT01098162 · clinicaltrials.gov ↗
COMPLETED
Status
576
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

UCB Pharma GmbH